PROVIDER PROFILE · NPI 1770791782
Dana BeausangM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
853
Unique beneficiaries
—
Total services
1,359
Distinct HCPCS
10
Medicare payment
$96K
Peer benchmark
Total Medicare services vs. 633 Endocrinology providers in CA — top quintile (cohort median 1,164).
PRESCRIBING · PART D · 2024
Total Rx claims
2,302
Beneficiaries
—
Total drug cost
$1.0M
Distinct drugs
32
Brand share
53.7%
Top prescribed drugs
Metformin Hcl192 claims
Semaglutide166 claims
Levothyroxine Sodium155 claims
Metformin Hcl142 claims
Empagliflozin136 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$40
Payment records
1
By payment type
Food and Beverage$40
Top paying entities
Food and Beverage$40
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
REFERRAL NETWORK
Where Dana Beausang's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 4 inbound referrers · 0 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Jon Keller Pathology · Palo Alto, CA | 181 | 1,159 |
| John Murao Diagnostic Radiology · Palo Alto, CA | 14 | 20 |
| Sean Hilchey Diagnostic Radiology · Fremont, CA | 14 | 19 |
| Soham Jhaveri, Do Internal Medicine · Fremont, CA | 11 | 20 |
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE